Sam Chun Dang Pharm Co, Ltd
Close-out letter issued May 13, 2020 · Hwaseong, South Korea
- Inspection
- Oct 17 – Oct 25, 2019
- Pages
- 6
- FEI number
- 3008425092
In short: On May 13, 2020, FDA sent Sam Chun Dang Pharm Co, Ltd in Hwaseong, Gyeonggi (FEI 3008425092) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Sam Chun Dang Pharm Co, Ltd inspected by FDA?
The inspection ran Oct 17 – Oct 25, 2019, and the Close-out letter is dated May 13, 2020.
How do I get the full Close-out letter for Sam Chun Dang Pharm Co, Ltd?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.